000 | 00908 a2200277 4500 | ||
---|---|---|---|
005 | 20250511212306.0 | ||
264 | 0 | _c19910823 | |
008 | 199108s 0 0 eng d | ||
022 | _a0361-8609 | ||
024 | 7 |
_a10.1002/ajh.2830370419 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRodgers, G M | |
245 | 0 | 0 |
_aLack of response to commercial factor VIII concentrate in hemophilia A. _h[electronic resource] |
260 |
_bAmerican journal of hematology _cAug 1991 |
||
300 |
_a288 p. _bdigital |
||
500 | _aPublication Type: Letter | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aDrug Contamination |
650 | 0 | 4 |
_aFactor VIII _xtherapeutic use |
650 | 0 | 4 |
_aHemophilia A _xtherapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
700 | 1 | _aFord, M H | |
773 | 0 |
_tAmerican journal of hematology _gvol. 37 _gno. 4 _gp. 288 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/ajh.2830370419 _zAvailable from publisher's website |
999 |
_c1913295 _d1913295 |